What is Neonatal Hemochromatosis

Neonatal Hemochromatosis is a rare, severe condition characterized by rapid, life-threatening liver failure in newborns due to excessive iron accumulation in the liver and other organs. It is now widely understood to be caused by gestational alloimmune liver disease, where the mother’s immune system attacks the fetal liver.

What causes Neonatal Hemochromatosis?

While historically thought to be a metabolic disorder, current research indicates that Neonatal Hemochromatosis is primarily an alloimmune process. In this mechanism, the mother produces antibodies (specifically IgG) that cross the placenta and target fetal liver cells. This immune-mediated injury leads to an inability of the liver to regulate iron, resulting in toxic iron overload throughout the infant's body.

How does Neonatal Hemochromatosis affect the body?

The primary impact of Neonatal Hemochromatosis is on the liver, causing severe inflammation and scarring (cirrhosis) that often begins before birth. Because the liver cannot manage iron levels, iron deposits in other vital organs. Common clinical manifestations include:

• Severe jaundice (yellowing of the skin and eyes)


• Bleeding tendencies due to poor clotting factor production


• Fluid accumulation in the abdomen (ascites)


• Low blood sugar (hypoglycemia)


• Organ damage in the heart and pancreas due to iron toxicity

Is Neonatal Hemochromatosis a hereditary condition?

Unlike classic hereditary hemochromatosis, Neonatal Hemochromatosis is not typically caused by a direct genetic mutation inherited from the parents. Instead, it is a recurrence-risk condition; mothers who have had one affected pregnancy have a high risk (often quoted between 60% and 80%) of having subsequent pregnancies affected by Neonatal Hemochromatosis, as the maternal antibodies persist.

How rare is Neonatal Hemochromatosis?

Neonatal Hemochromatosis is an extremely rare disorder. While exact global incidence rates are difficult to pinpoint due to historical misdiagnosis, it is estimated to occur in approximately 1 in 50,000 to 1 in 100,000 live births. Within the DiseaseMaps.org community, 42 people have shared their experiences, highlighting the importance of specialized care for this rare diagnosis.

Next steps

• Consult a pediatric hepatologist or neonatologist immediately if a diagnosis is suspected.


• Discuss the potential for intravenous immunoglobulin (IVIG) therapy with your medical team, as it is often used to treat and prevent Neonatal Hemochromatosis in high-risk pregnancies.


• Join the DiseaseMaps.org community to connect with other families navigating this journey.


• Request a referral to a high-risk obstetrician (maternal-fetal medicine specialist) for future pregnancy planning.

Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment.

References

• NIH Genetic and Rare Diseases Information Center (GARD)


• Orphanet: Portal for rare diseases and orphan drugs


• OMIM (Online Mendelian Inheritance in Man)


• Journal of Pediatric Gastroenterology and Nutrition (Clinical Reviews)